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Herbal products are marketed and used around the globe for their claimed or expected
health benefits, but their increasing demand has resulted in a proportionally increase of
their accidental contamination or intentional adulteration, as already confirmed with DNA-
based methods. Microscopy is a traditional pharmacopoeial method used for plant
identification and we systematically searched for peer-reviewed publications to
document its potential and limitations to authenticate herbal medicines and food
supplements commercially available on the global market. The overall authenticity of
508 microscopically authenticated herbal products, sold in 13 countries, was 59%, while
the rest of 41% were found to be adulterated. This problem was extending over all
continents. At the national level, there were conspicuous differences, even between
neighboring countries. These microscopically authenticated commercial herbal products
confirm that different magnifying instruments can be used to authenticate crude or
processed herbal products traded in the global marketplace. The reviewed publications
report the successful use of different magnifying instruments, single or in combinations
with a second one, with or without a chemical or DNA-based technique. Microscopy is
therefore a rapid and cost-efficient method, and can cope with mixtures and impurities.
However, it has limited applicability for highly processed samples. Microscopic
authentication of commercial herbal products will therefore contribute to raise public
awareness for the extent of adulteration and the need to safeguard consumer safety
against the challenges of globalization.
Keywords: light microscopy, electron microscopy, authentication, plant identification, food supplement, traditional
medicine, herbal product, consumer safetyINTRODUCTION
Herbal products are a heterogeneous category of goods which are produced, marketed, and used
around the globe for their claimed or expected health benefits. Their commercial names depend on
their final declared use (i.e., medicines or foods), and the prevailing legal frameworks and regulatory
requirements (Simmler et al., 2018), such that they are sold under different names, such as herbalin.org June 2020 | Volume 11 | Article 8761
Ichim et al. Microscopic Authentication of Herbal Productsdrugs, botanical drugs, botanicals, phytomedicines, traditional
medicines, herbal medicines, traditional Chinese medicines
(TCMs), traditional herbal medicinal products, natural health
products, or plant food supplements (Ichim, 2019).
The use of herbal medicinal products and supplements has
increased tremendously over the past decades with a substantial
proportion of the world’s population relying on them as element
of primary healthcare (Ekor, 2014). The global market for herbal
products is rapidly expanding and expected to reach 115,000
million US$ in 2020 (Raclariu et al., 2018a) while the trade of
medicinal plants will continue to advance with annual growth
rates of 15–25% (Booker et al., 2012). This increasing demand for
plant-based products has resulted in a proportionally increase of
peer-reviewed reports of accidental contamination or
intentional, economically motivated adulteration (de Boer
et al., 2015; Ichim et al., 2018; Simmler et al., 2018; Grazina
et al., 2020; Grosu and Ichim, 2020). A global analysis of nearly
6,000 herbal products sold in 37 countries has revealed that 27%
of the products contain undeclared contaminants, substitutes, or
filler species (Ichim, 2019). To address this problem, DNA
barcoding as powerful strategy has recently attracted
considerable attention and, along with chemical methods (de
Boer et al., 2015; Pawar et al., 2017; Sgamma et al., 2017), has
started to enter the regulatory systems for quality control
(Pharmacopoeia Committee of P. R. China, 2015; British
Pharmacopoeia Commission, 2018).
However, DNA-based diagnostics of processed food products
or of mixtures from different plants can sometimes be
challenging (Raclariu et al., 2018b; Grazina et al., 2020), such
that this principally powerful approach has to be complemented
by alternative methods (Sgamma et al., 2017). Microscopy has
long been used to identify herbal products in many countries, as
recorded in many pharmacopoeias, because of its advantages of
small amount of sample needed, speed, reliability, simplicity, and
low costs (Au et al., 2009). Moreover, histochemical techniques
have been used to reveal the characteristics of tissue structure
and cellular features that can be used as markers for species
identification (Au et al., 2009).
Since they are often taxon-specific, in some cases even
down to the species level, the morphological, anatomical, and
microscopic characteristics of plant species are of great value
for the purposes of scientific investigation and botanical
quality control (Grazina et al., 2020). These characteristics
can be used to verify plant authenticity, and to detect
contaminations, adulterations, and substitutions in plant
products (Michetti et al., 2019). Microscopic authentication
refers to the analysis of structural, cellular and molecular
features of herbal products using different forms of
microscopy (Tam et al., 2006). While macroscopic and
microscopic examinations are easily applied to fresh whole
plants or plant parts, dried products, as those typically sold on
the market, are generally difficult to identify, as many useful
diagnostic characteristics are lost during dehydration
(Joharchi and Amiri, 2012). In addition, often macroscopic
or microscopic examinations will fail because a preparation
consists of multi-component powdered samples that haveFrontiers in Pharmacology | www.frontiersin.org 2been processed beyond the extent that would allow
morphological characterizations (Pawar et al., 2017).
Rather than to extend the rampant increase of peer-reviewed
single-case reports on adulteration of commercial herbal
products, this mini-review strives to give a survey on the
documented ultimate real-case scenario of all: the global
market of herbal products. What are potential and limitations
of microscopic food diagnostics in detecting substitution and
adulteration in order to safeguard consumer safety in a
globalized economy?METHODS
Search Strategy
We systematically searched four databases for relevant peer-
reviewed studies following the PRISMA guidelines (on 17
January 2020) (Moher et al., 2009). Combinations of relevant
keywords, Boolean operators and wildcards were used:
[(“medicinal plant” OR herbal OR botanical OR nutraceutical
OR TCM) AND (microscop* OR histolog* OR morpholog*)
AND (identification OR authentication OR adulteration)] for
Web of Science, PubMed, and Scopus, and [(“medicinal plant”
OR herbal OR botanical OR nutraceutical) AND (microscopy
OR microscopical OR histological) AND (identification OR
authentication)] for ScienceDirect, due to limitations imposed
by the latter search engine. The option “search alert” was
activated for all the databases, to receive weekly updates after
the search was performed.
Selection Process and Criteria
Identification: 4,406 records were identified through database
searching (WoS = 998, PubMed = 846, Scopus = 2,426, and
ScienceDirect = 136), and additional 174 records through
other sources.
Screening: 2,326 records were retrieved and their abstracts
screened after the duplications had been removed. After
screening, 2,062 records were excluded for not reporting data
relevant to the microscopic authentication of herbal products.
Eligibility: 264 full-text articles were assessed and screened
based on the following eligibility criteria:
1. The reported samples had to be “herbal products” sensu lato.
A wide range of commercial names was searched for and
accepted for inclusion into our analysis, all falling under two
main categories: medicines or foods, with claimed or at least
expected health benefits.
2. The products had to be clearly allocated to a “country” or
“territory” (i.e., Hong Kong).
3. The conclusion “authentic”/”adulterated” (or similar) had to
be drawn by the authors of the analyzed studies. Our
involvement was restricted to operations such as counting
the samples, transforming percentages in absolute numbers,
without reinterpreting the experimental results in any way.
4. The samples had to be authenticated with a magnifying
instrument. A wide variety of instruments were accepted,June 2020 | Volume 11 | Article 876
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morphological authentication with the naked eye was
excluded from our analysis.
5. The products had to have a commercial value. Studies where
the analyzed samples were “collected”, obtained “cost-free”, a
“gift” or “donated” by a person, institution or company, were
excluded.
The set of retrieved full-text articles was further reduced by
236 that did not meet all five eligibility criteria.
Included: 28 peer-reviewed articles.RESULTS
Our systematic literature search identified 28 peer-reviewed
publications reporting the use of magnifying instruments for
the successful authentication of 508 commercial herbal products.
In average, the reviewed articles reported the results for 18 herbal
products, the number varying from 1 product (Liu et al., 2013;
Czigle et al., 2018) to as many as 86 commercial samples (Walker
and Applequist, 2012). In 13 articles, the light microscope was
reported as the only instrument used for authentication, being
successfully used for a total of 226 products, while the remaining
studies included a second magnifying instrument, from hand
lenses and stereo-microscopes till scanning electron
microscopes, for the analysis of the remaining 282 products.
Besides, in 20 articles at least one additional technique (DNA-
or/and chemistry-based methods) was used to test authenticity.
Yet, in eight studies, the exclusive use of microscopy was
successfully authenticating a total of 358 commercial herbal
products (Table 1).
We have reviewed the authenticity results for 508 herbal
medicines and food supplements traded in thirteen countries or
territories (i.e., Argentina, Brazil, China, Egypt, Hong Kong,
Germany, Greece, India, Iran, Peru, Thailand, Turkey, and USA),
geographically representing all inhabited continents, except
Australia. For two countries (i.e., Argentina and USA), more
than 100 commercial herbal products have been analyzed and
microscopically authenticated from their respective national
marketplace. For additional six countries (i.e., Brazil, China,
Germany, Hong Kong, Iran, and Thailand), more than 10
herbal products were analyzed, while for Egypt, Greece, India,
Peru, and Turkey, 10 products or less were reported (Figure 1).
The overall authenticity of the microscopically authenticated
commercial herbal products from the global marketplace was 59%
(n = 300 products), while the rest of 41% (n = 208 products) were
found to be adulterated (Table 1). All or at least most (>70%)
products were reported to be authentic in Argentina (n = 135),
China (n = 40), Germany (n = 38), Thailand (n = 4), and Egypt
(n = 2). In the USA (n = 128) and Peru (n = 2), a substantial part (>
30%) was wrongly declared, and a third group of countries,
comprising Iran (n = 70), Brazil (n = 30), India (n = 10), Turkey
(n = 10), and Greece (n = 1) showed authenticity score is lower
than 40%. It should be kept in mind that the numbers of samples
was geographically heterogeneous: At continental level, the highest
number of commercial herbal products was reported for SouthFrontiers in Pharmacology | www.frontiersin.org 3America (n = 167), followed very closely by Asia (n = 164), by
North America (n = 128) and, distantly, by Europe (n = 49).
Instead, almost half (49%) of the total products (n = 167)
microscopically authenticated in Asia were reported to be
adulterated, followed by South America (40%), Europe (39%),
and more distantly by North America (33%).DISCUSSION
Our survey on the extent of herbal adulteration as detected by
microscopical diagnostics supports a previous study using DNA-
based authentication (Ichim, 2019). On the global scale, almost
half of herbal products did not contain, what they declared.
However, there are substantial differences between the different
national markets, sometimes even between neighboring
countries, such as Argentina (with a high authenticity score
among the 135 tested products) and Brazil (with a low
authenticity score among the 30 tested products). In the
following, we will discuss to what extent this startling outcome
is robust against unavoidable sampling bias, and what the
potential and the limitations of microscopic diagnostics are.
Using two case studies, we will address possible reasons for
this high degree of adulteration, and conclude by deriving some
suggestions, how consumer protection can be safeguarded in
times of globalization.
Sampling Heterogeneity and Its Reasons
The frequency of adulteration in the current study exceeds that
seen for the study based on DNA authentication (Ichim, 2019).
This might stem from the fact that the sample size is different
(DNA authentication: n = 5,957; microscopic authentication: n =
508) by a factor of ten. There are different reasons for this
obvious sampling bias: to publish results from a traditional
method in peer-reviewed journals is much more difficult as
compared to publishing DNA-based, “new” diagnostic
approaches. The countries with a functional consumer safety
system might be underrepresented as the authentication results
of the commercial samples screened by the respective institutions
will be published in internal bulletins or protocols, rather than in
peer-reviewed journals. There is a second, methodological
reason, though: microscopic diagnostics requires not only
patience, exact observation, and long experience, but also deep
knowledge of plant anatomy and plant biodiversity. This
expertise is currently lost rapidly in most countries, and may
be one reason, why some countries are not represented in our
sampling. The comparison of Brazil (n = 30, most adulterated)
and Argentina (n = 178, most authentic) indicates a further
reason for sampling bias: the lack of methodological expertise
may also correlate with a lack of consciousness that there is a
serious problem.
Prospects and Limitations of Microscopic
Diagnostics
Our current study clearly confirms previous results (Gao et al.,
2017) that a substantial proportion of commercial herbalJune 2020 | Volume 11 | Article 876









































































































































China Traditional herbal tea “Ku-Ding-Cha” from markets & manufacturers (intact or fragmented dried
leaves or powders)/Ilex kudingcha C.J.Tseng, I. latifolia Thunb., Ligustrum robustum (Roxb.) Blum,
Clerodendrum fortunatum L., Ehretia acuminata R.Br.
plant samples (Y) 19 19
China Radix Polygoni Multiflori (Heshouwu)/dried root tuber of Reynoutria multiflora (Thunb.) Moldenke n/a 12 12
China traditional “Xihuangcao” herbal tea bags from retail stores/Isodon lophanthoides (Buch.-Ham. ex




China Menispermi Rhizoma from a drug store/dried rhizome of Menispermum dauricum DC. n/a 1 0
Egypt slimming herbal tea products/Cichorium intybus L., Urtica dioica L., Origanum majorana L., Senna
alexandrina Mill. leaves, Glycyrrhiza glabra L. roots, Apium graveolens L. fruits, Calendula officinalis








Cordyceps sinensis purchased fermented samples and supplements (capsules)/C. sinensis, C.
hawkesii, C. liangshanensis, C. militaris
collected samples (Y) 15 4
Hong
Kong
traditional crude drug “Wuzhimaotao” (Radix Fici Hirtae) (primarily dried roots of Ficus hirta Vahl)/F.
hirta Vahl, F. simplicissima Lour., F. esquiroliana H.Lév
plants (Y) 5 3
India Ayurvedic crude drug “Daruharidra” (roots of Berberis aristata DC.) from drug markets/B. aristata
DC., B. asiatica Roxb. ex DC., B. chitria Buch.-Ham. ex Lindl., B. lyceum Royle
plants (N) 10 0
Iran crude raw material of herbal drugs/27 cases of herbal drugs n/a 78 30
Thailand white “KwaoKrua” products from local markets/Pueraria candollei Benth. plant leaves (Y) 7 7




Germany “Goji” products (dried fruits)/Lycium barbarum L., L. chinense Mill., L. ruthenicum Murray fruits, L.
europaeum L., L. chilense Bertero, L. ameghinoi Speg.
whole plants (Y), fruits,
DNA (Y)
19 19
Germany three bamboo teas and five fruit teas containing bamboo leaves/bamboo (Bambusoideae),
lemongrass (Cymbopogon)
plants (Y) 8 4
Germany commercial tea mixtures containing ‘Lemon Myrtle’/Backhousia citriodora F.Muell., Leptospermum
petersonii F.M.Bailey
plants (Y) 4 4































































































































Germany Holy Basil ‘Tulsi’ mixtures (mixture teas, cut leaf fragments)/Ocimum tenuiflorum L., O. basilicum
L., O. serratum (Schltr.) A.J.Paton, O. gratissimum L.
plants (Y) 4 0
Germany tea mixtures/Dracocephalum moldavica L. plants (Y) 3 3
Greece powdered Ginkgo leaf food supplement purchased in local community pharmacy/G. biloba L. n/a 1 0
Turkey leaf products from different herbal shops/Eucalyptus camaldulensis Dehnh., E. globulus Labill., E.
grandis W.Hill
plants (Y) 10 0
Europe 49 30
USA unprocessed products containing botanicals purchased from retail outlets/Arnica Montana L.,
Arnica sp., Matricaria chamomilla L., Crataegus sp., Juniperus communis L., Tilia sp., Hypericum
perforatum L., Schisandra sp., Scutellaria lateriflora L., Illicium verum Hook.f.
n/a 86 65
USA “buchu” commercial raw materials and finished products/Agathosma betulina (P.J.Bergius) Pillans,




USA commercial “yohimbe” raw products/Pausinystalia johimbe (K.Schum.) Pierre ex Beille plant bark (Y) 12 9
USA Hoodia gordonii (Masson) Sweet ex Decne. capsules/Hoodia sp., Opuntia ficus-indica (L.) Mill.,
Ceropegia dichotoma Haw., Cynanchum sp., Edithcolea grandis N.E.Br., Huernia sp., Orbea sp.,
Piaranthus globosus A.C. White & B. Sloane, Stapelia sp., Tridentea choanantha (Lavranos &







Argentina single ingredient herbal products (mostly fragmented)/various species n/a 64 44





Argentina fine cut (tea bags) and thick cut (fragmented herbs) mixtures/21 different species n/a 11 7
Argentina dietary supplements from local market/Arthrospira sp. n/a 1 0.
u
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Frontiers in Pharmacology | www.frontiersin.org 6products are adulterated. Despite the caveat on sampling bias, it
can also be concluded that microscopic diagnostics can detect
adulterations more thoroughly than DNA-based authentication
alone. The microscopically authenticated products were
purchased from a wide variety of markets and shops, and were
processed for quite diverse purposes. Thus, microscopic
authentication is robust enough to be used along local,
national, and international value chains for herbal products
(Booker et al., 2012; Heinrich et al., 2019). Qualitative cellular
and anatomical details, such as calcium oxalate crystals,
idioblasts, xylem cells, stone cells, or stomatal complexes are
well covered by monographies forming the base for
pharmacopeias (Tam et al., 2006). In difficult cases,
morphologica l ident ificat ion can be supported by
histochemical analysis to detect diagnostic features of the
specimen (Au et al., 2009). In addition, microscopy allows to
trace contamination by non-plant materials, such as insects or
even inanimate matter, which would go unnoticed in a DNA-
based test, such as pieces of wire, nylon, soil, stones, or sand
(Cuassolo et al., 2010; Michetti et al., 2019). Despite these
undisputable advantages, microscopic diagnostics also has to
face several challenges: for the often exotic species,
monographies on their diagnostic characteristics are not
available and have to be newly established. A precondition for
this endeavor is the availability of authentic reference material,
either from wild or cultivated resources, Botanical Gardens,
germplasm centers, or herbarium vouchers. The validation
and verification of such reference materials is an absolute
must. Unfortunately, a substantial fraction of these materials
are mislabeled as well (Goodwin et al., 2015), because “Rapidly
increasing numbers of specimens in an increasing numbers of
herbaria are not being revived because there are too few
taxonomists”. Some microscopical techniques, such as SEM,
require expensive equipment, which may not be affordable in a
lab. TEM in particular, requires extensive sample processing,
such as fixation, embedding, ultrasectioning, and contrasting,
which easily can introduce artifacts that are misleading, if the
user is not very experienced. A further challenge for
microscopic diagnostics are heavily processed products, such
as finely cut material or ground powders. Although one can try
to process the collected reference plant material in a similar
manner to match the commercial products, often the
diagnostic features are lost.
Herbal Adulteration as Product of
Economic Incentive and Ambiguous
Nomenclature
There seem to be mainly two drivers for adulteration: (i) limited
supply and high dynamics of demand; (ii) ambiguities of
traditional versus scientific nomenclature. In the following,
both factors are exemplarily discussed. Optical microscopy can
help here to screen out in a robust and cost-effective way,
samples that appear suspicious and might deserve closer
scrutiny also involving other, more laborious, and more
expensive, methods. The connection between limited supply,
sky-rocketing demand, and the use of light microscopy can be






















































































































































































































































































































































































































































































































































































June 2020 | Volume 11 | Article 876
Ichim et al. Microscopic Authentication of Herbal ProductsOptical Microscopy—A Cheap Technique to Operate
Can Detect Adulteration in a Multi Billion Industry
The insect-parasitic fungus Cordyceps sinensis is widely used and
valued in Asian traditional medicine (Elkhateeb et al., 2019), but
endemic to a very restricted area in the Tibetan plateau (Li et al.,
2011). In the meantime, it has been recognized to be not related to
other members of the genus and has been renamed as
Ophiocordyceps sinensis. During the last decade, Cordyceps had
been discovered as “superfood” and is now amply used as
supplement for food supplements. The combination of
restricted habitat and increasing demand have led to over-
harvesting and a dramatic rise in its price (Liu et al., 2011). The
market volume of traded products declared as Cordyceps exceeds
the annual harvest of O. sinensis by a factor of 20 and has reached
470 million USD in 2018. Around 70% seems to be in fact the only
distantly related parasitic species C. militaris (GlobeNewswire,
2019). The economic gain of this adulteration is tremendous: the
crude drug was already at 13,000 USD/kg in 2008, but has
skyrocketed to USD $20,000 to 40,000 per kg within 5 years (Lo
et al., 2013). In this context, light microscopy was successful to
authenticate these products, no matter, whether marketed, as raw
fruiting body (Nopparat et al., 2018), or in fermented or processed
form as capsules (Au et al., 2012).
Traditional Nomenclature Can Cause Non-Intentional
Adulteration: The Case of Bamboo Tea
Traditional nomenclature is not based on phylogenetic
relationship, but on common use (Berlin et al., 1966).
Globalization shifts plants out from their traditional functional
context, and this represents a major source for non-intentionally
adulteration, as exemplarily addressed for the product Bamboo
tea (Horn and Häser, 2016), which appeared on the European
market from the mid of the last decade. Bamboo belongs to the
Poaceae with characteristic dumbbell-shaped guard cells. When
leaf fragments of this product were investigated by bright-field
microscopy, instead, kidney-shaped guard cells with twoFrontiers in Pharmacology | www.frontiersin.org 7subsidiary cells, arranged in parallel rows, were seen. This
diacytic stoma type was definitely not consistent with the
declared Poacean ingredients, but rather pointed to a specimen
of the genus Dianthus (carnation). This could be confirmed
using the plastidic markers matK and rbcL. Different accessions
from this genus were then purchased from different Botanical
Gardens and commercial sources and taxonomically verified to
serve as references. When the histology of completely developed
leaves from these plants was investigated by microscopy, the
samples could be assigned to the species Dianthus chinensis L.
The background of this curious case of adulteration (bamboo
and carnation are evolutionarily far apart) is to be sought in the
problematic use of vernacular names in commercial products.
The young leaves of the bamboo species Sasa palmate (Burb.)
E.G.Camus, Sasa kuriliensis (Rupr.) Makino & Shibata, and
Lopaterum gracile have a long history in TCM and are
supposed to support the breakdown of body sediments
including fat. They are traded under the name Dan Zhu Ye.
Also Chinese carnation (Dianthus chinensis L.) is used in TCM,
but for a different purpose (for instance, it acts diuretically).
Since the leaves of this plant resemble young bamboo leaves, and
since it is a traditional component of Chinese Stone Gardens, it is
often called Shi Zhu (“Stone Bamboo”). In the context of TCM, it
is fairly clear, what plant is handled. However, the rapid increase
in consumer demand had caused bottlenecks in the producing
countries. When supply is under constraint, the internet search
for Bamboo tea can easily lead to the purchase of products that
are branded as “Bamboo Carnation Tea”. This had happened in
the current case, and again underlines, how important it is to
install a systematic authentication of commercial products,
preferably already in the harbors, where the material enters the
industrial supply chain.
Concluding Remarks
The use of microscopy and molecular markers as diagnostic
tools for the authentication of plant food ingredients is rarelyFIGURE 1 | Numbers of commercial herbal products verified by microscopical diagnostics over different countries. Products, where authentication confirmed the
declared content are given in green, products, where the declaration was falsified, in red. The fraction of correctly declared products in a given country is indicated
by the authenticity score.June 2020 | Volume 11 | Article 876
Ichim et al. Microscopic Authentication of Herbal Productsused in combination. However, this would be important,
because each of the two approaches has individual
advantages and disadvantages. Microscopy is a rapid and
cost-efficient method, and can cope with mixtures and
impurities. However, it has limited applicability for highly
processed samples. It is important to keep this art alive as
essential part of university curricula. It is also important to
raise public awareness for the extent of adulteration and the
need to safeguard consumer safety against the challenges
of globalization.AUTHOR CONTRIBUTIONS
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